Metraipolis › archive › dc_713b60792adb

Targeting the CXCR4/CXCL12 Axis to Overcome Drug Resistance in Triple-Negative Breast Cancer — Europe PMC PMID:41002447

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41002447
DOI
10.3390/cells14181482
License (as archived)
solo-consultazione
Archived
2026-11-09T20:17:28.354Z
SHA-256 of the archived text
bf54ed36c29ebd3e5080f65aa86bc24094feecccea1843996596465bb9a2cf27
Stable URL of this page
https://metraipolis.com/documento/dc_713b60792adb

How to cite

Targeting the CXCR4/CXCL12 Axis to Overcome Drug Resistance in Triple-Negative Breast Cancer — Europe PMC PMID:41002447 — Europe PMC (en), https://europepmc.org/article/MED/41002447 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_713b60792adb (Metraipolis archive dc_713b60792adb, sha256 bf54ed36c29ebd3e5080f65aa86bc24094feecccea1843996596465bb9a2cf27)
BibTeX
@misc{dc713b60792adb,
  title = {Targeting the CXCR4/CXCL12 Axis to Overcome Drug Resistance in Triple-Negative Breast Cancer — Europe PMC PMID:41002447},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41002447},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_713b60792adb; sha256 bf54ed36c29ebd3e5080f65aa86bc24094feecccea1843996596465bb9a2cf27},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41002447. Agents can read the archived copy with the MCP tool read_document.